CPK (MB)

This diagnostic test, conducted by Hypro Diagnostics, measures the concentration of the CK-MB isoenzyme in the blood, offering insights into potential heart muscle damage. CK-MB, a specific form of creatine kinase primarily located in the heart, is released into the bloodstream when heart muscle cells are compromised, such as during a heart attack. Despite CK’s presence in multiple organs, elevated CK-MB levels are particularly indicative of cardiac issues. While CK-MB testing has been historically employed for heart attack diagnosis, Hypro Diagnostics recognizes the evolving landscape, with cardiac troponin tests now being favored for their superior specificity and sensitivity. This shift underscores the commitment to providing advanced and precise diagnostic solutions, enabling healthcare providers to accurately distinguish between individuals with diverse causes of chest pain and those experiencing a genuine cardiac event.